Texting with 'Penny' to beat lung cancer: can a chatbot improve medication adherence?
NCT ID NCT04347161
Summary
This study is testing if a text-message chatbot named 'Penny' can help people with lung cancer remember to take their daily oral medications and manage side effects. Researchers are comparing the chatbot to usual care in 75 patients to see if it improves how consistently patients take their pills. The goal is to find better ways to support patients on these important long-term treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDICATION ADHERENCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.